Enjoy Free Shipping on Orders above $220
10% off on orders over $120 up to $20 Use Code: MYVAL10
Actorise 25 Injection is a prescribed Erythropoiesis-Stimulating Agent (ESA) for managing Anemia in patients undergoing chemotherapy or diagnosed with Chronic Kidney Disease (CKD). It contains Darbepoetin alfa, an ESA that encourages the bone marrow to produce more red blood cells, thereby reducing the need for blood transfusions and improving oxygen transport.
This injectable medication is strictly administered under medical supervision and is primarily prescribed for patients undergoing dialysis or chemotherapy. It helps manage Anemia-related fatigue and weakness, improving overall well-being. The dosage varies based on individual hemoglobin levels, and proper adjustments are necessary to prevent complications like hypertension or cardiovascular risks. Regular blood tests are crucial to monitor progress and effectiveness.
Cipla Ltd manufactures Actorise 25, which must be stored in a refrigerator to maintain potency. Freezing or shaking the injection may affect its stability, so it should be handled carefully. Always check the expiration date before use and strictly follow the prescribed storage guidelines to ensure its effectiveness.
Actorise 25 provides essential benefits for managing Anemia. Key benefits include:
Actorise 25 is a prescription-only medication and should be administered under a healthcare professional's supervision. It is given as an injection either intravenously (into a vein) or subcutaneously (under the skin) based on medical advice.
General guidelines include:
Actorise has various strengths and substitutes. Your doctor may adjust your dosage based on your specific condition and response to treatment.
Available strengths include:
| $43.41/ Injection | |
| $98.65/ Injection | |
| $184.11/ Injection |
Generally safe when taken as prescribed, but some may experience mild to moderate side effects:
Seek medical help if any side effects persist or worsen.
Liver disease
Patients with liver problems should use Actorise 25 cautiously as the liver metabolizes medications. Regular monitoring and dose adjustments may be required under medical supervision.
Kidney impairment
Actorise 25 is mainly for chronic kidney disease patients but requires regular hemoglobin level monitoring. Patients with advanced kidney disease should use this medication strictly under nephrologist guidance.
Pregnant and breastfeeding women
Actorise 25 should only be used during pregnancy or breastfeeding if prescribed by a doctor. The medication can cross the placenta or enter breast milk, so careful medical supervision is essential.
Avoid
Avoid driving or operating machinery if you experience dizziness or headaches while using this medication. Do not consume alcohol, as it can increase side effects and interfere with the treatment's effectiveness.
Actorise Injection is primarily used for Chronic Kidney Disease (CKD)-induced Anemia and chemotherapy-induced Anemia. It helps improve hemoglobin levels and reduces the need for blood transfusions.
The dosage varies based on the patient's hemoglobin levels and response to treatment. It is usually given once weekly or once every two weeks via subcutaneous or IV injection under medical supervision.
Yes, Actorise Injection is commonly prescribed to dialysis patients suffering from Anemia due to Chronic Kidney Disease (CKD). It helps maintain adequate hemoglobin levels and reduce fatigue.
Yes, it is approved for use in chemotherapy-induced Anemia. However, it must be used with caution as it can increase the risk of tumor progression in specific cancers. Your doctor will assess the risks before prescribing.
Yes, in rare cases, Actorise 25 Injection may increase the risk of blood clots, especially in patients with pre-existing cardiovascular conditions. Regular monitoring and following the prescribed dosage can minimize the risk.
If you miss a dose, contact your doctor immediately for guidance. Do not take a double dose to make up for a missed one. Your doctor will advise on the next best step based on your condition.
The effects of Actorise Injection are gradual. Patients typically notice hemoglobin levels and energy improvements within a few weeks of starting the treatment. However, regular blood tests are needed to monitor progress.
